CD8A and neoplasm: Flow cytometry assays were performed to detect changes in cytotoxic immune cell subtypes, including CD8+ T cell and natural killer (NK) cell subsets, in tumor tissues after 24 or 36 h of treatment with CIBT4523 and CIBT4503.